Search

CBR1 Blockade and New Anti-Obesity Drugs Development: Targeting the Adipose Tissue

Ebook: Anti-Obesity Drug Discovery and Development
Volume: 1 Year: 2011
Author(s): Laurence Hoareau,Karima Bencharif,Regis Roche
Doi: 10.2174/978160805163211101010229

Rimonabant for the Treatment of Obesity

Journal: Recent Patents on Cardiovascular Drug Discovery (Discontinued)
Volume: 3 Issue: 3 Year: 2008 Page: 187-193
Author(s): Ashish Samat, Brian Tomlinson, Shahrad Taheri, G. Neil Thomas

Journal: Current Drug Safety
Volume: 4 Issue: 1 Year: 2009 Page: 2-4
Author(s): David Taylor

Recent Advances in Obesity Pharmacotherapy

Journal: Current Clinical Pharmacology
Volume: 4 Issue: 1 Year: 2009 Page: 53-61
Author(s): Marcos A. Mayer, Christian Hocht, Ana Puyo, Carlos A. Taira

Endocannabinoid Blockade and the Cardiovascular System

Journal: Current Drug Therapy
Volume: 4 Issue: 2 Year: 2009 Page: 111-116
Author(s): Oliver P. Keown, Ian L. Megson, Stephen J. Leslie

Pleiotropic Effects of Rimonabant: Clinical Implications

Journal: Current Pharmaceutical Design
Volume: 15 Issue: 5 Year: 2009 Page: 553-570
Author(s): Jean-Pierre Despres

Targeting MCP-1 to Reduce Vascular Complications of Obesity

Journal: Recent Patents on Cardiovascular Drug Discovery (Discontinued)
Volume: 4 Issue: 3 Year: 2009 Page: 164-176
Author(s): Miina K. Ohman, Daniel T. Eitzman

The Activated Endocannabinoid System in Atherosclerosis: Driving Force or Protective Mechanism?

Journal: Current Drug Targets
Volume: 16 Issue: 4 Year: 2015 Page: 334-341
Author(s): Sabine Steffens,Pal Pacher

Visceral Adipose Tissue and Atherosclerosis

Journal: Current Vascular Pharmacology
Volume: 7 Issue: 2 Year: 2009 Page: 169-179
Author(s): Miina K. Ohman, Andrew P. Wright, Kevin J. Wickenheiser, Wei Luo, Daniel T. Eitzman

Prevalence of Obesity: The Global Epidemics

Ebook: Anti-Obesity Drug Discovery and Development
Volume: 1 Year: 2011
Author(s): Ya-Wen Hsu,Po-Wen Ku,Da-Chen Chu,Tsan-Hon Liou,Pesus Chou
Doi: 10.2174/978160805163211101010001